Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy

被引:90
|
作者
Biteker, Murat [1 ]
Ilhan, Erkan [2 ]
Biteker, Gul [3 ]
Duman, Dursun [1 ]
Bozkurt, Biykem [4 ,5 ]
机构
[1] Haydarpasa Numune Educ & Res Hosp, Dept Cardiol, Istanbul, Turkey
[2] Siyami Ersek Cardiovasc Surg Ctr, Dept Cardiol, Istanbul, Turkey
[3] Ortaca Yucelen Hosp, Dept Obstet & Gynecol, Istanbul, Turkey
[4] Baylor Coll Med, Dept Med, Cardiol Sect, Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA
[5] Baylor Coll Med, Winters Ctr Heart Failure Res, Houston, TX 77030 USA
关键词
Peripartum cardiomyopathy; Late recovery; Treatment; ECHOCARDIOGRAPHY; RECOMMENDATIONS; PREDICTORS; PROGNOSIS; SOCIETY; HEART;
D O I
10.1093/eurjhf/hfs070
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Persistence of left ventricular (LV) systolic dysfunction after 6 months of diagnosis is believed to be a marker of an irreversible cardiomyopathy in peripartum cardiomyopathy (PPCM). We sought to determine the length of time required for recovery of LV systolic function (LVSF) in patients with PPCM. Forty-two consecutive women with PPCM were enrolled in this prospective study. The minimum required time of follow-up for inclusion was 30 months. Each patient underwent transthoracic echocardiography, and plasma brain natriuretic peptide (BNP) and C-reactive protein measurement at admission, and every 3 months. Early recovery was defined as normalization of LVSF at 6 months post-diagnosis. Delayed recovery was defined if the length of time required for recovery of LVSF was longer than 6 months. Persistent left ventricular dysfunction (PLVD) was defined as an ejection fraction of 50 at the end of follow-up. Twenty patients (47.6) recovered completely, 10 died (23.8), and 12 (28.6) had PLVD. Average time to complete recovery was 19.3 months after initial diagnosis (342 months). Early recovery was observed only in six patients (30), whereas delayed recovery was observed in 14 out of 20 patients (70). Patients with complete recovery were more likely to have a higher LV ejection fraction and smaller LV end-systolic dimensions at baseline. Full recovery of LVSF in PPCM patients often requires longer than 6 months.
引用
收藏
页码:895 / 901
页数:7
相关论文
共 50 条
  • [21] LONG-TERM FOLLOW-UP AND THERAPY IN MULTIPLE MYELOMA
    VELEZGAR.E
    MALDONADO, N
    CANCER, 1971, 27 (01) : 44 - +
  • [22] Rituximab therapy in pemphigus: A long-term follow-up
    Loi, Camilla
    Magnano, Michela
    Ravaioli, Giulia Maria
    Sacchelli, Lidia
    Patrizi, Annalisa
    Bardazzi, Federico
    DERMATOLOGIC THERAPY, 2019, 32 (01)
  • [23] Long-term follow-up of aggressive therapy in neurosarcoidosis
    Yandora, K
    Valeri, A
    Schramke, CJ
    Scott, TF
    NEUROLOGY, 2006, 66 (05) : A188 - A188
  • [24] Long-term follow-up of occlusion therapy in amblyopia
    Leiba, H
    Shimshoni, M
    Oliver, M
    Gottesman, N
    Levartovsky, S
    OPHTHALMOLOGY, 2001, 108 (09) : 1552 - 1555
  • [25] Long-Term Follow-Up of Mechanical Circulatory Support in Peripartum Cardiomyopathy (PPCM) Refractory to Medical Management: A Multicenter Study
    Jawad, Khalil
    Koziarz, Alex
    Dieterlen, Maja-Theresa
    Garbade, Jens
    Etz, Christian D.
    Saeed, Diyar
    Langer, Elena
    Stepan, Holger
    Scholz, Ute
    Krause, Michael
    Brenner, Paolo
    Schulz, Uwe
    Borger, Michael A.
    Eifert, Sandra
    LIFE-BASEL, 2022, 12 (01):
  • [26] The beneficial effects of postinfarct cytokine combination therapy are sustained during long-term follow-up
    Sanganalmath, Santosh K.
    Stein, Adam B.
    Guo, Yiru
    Tiwari, Sumit
    Hunt, Greg
    Vincent, Robert J.
    Huang, Yiming
    Rezazadeh, Arash
    Ildstad, Suzanne T.
    Dawn, Buddhadeb
    Bolli, Roberto
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2009, 47 (04) : 528 - 535
  • [27] Long-term follow-up of sustained responders to interferon therapy, in patients with chronic hepatitis C
    Toyoda, H
    Kumada, T
    Tokuda, A
    Horiguchi, Y
    Nakano, H
    Honda, T
    Nakano, S
    Hayashi, K
    Katano, Y
    Nakano, I
    Hayakawa, T
    Nishimura, D
    Kato, K
    Imada, K
    Imoto, M
    Fukuda, Y
    JOURNAL OF VIRAL HEPATITIS, 2000, 7 (06) : 414 - 419
  • [28] Long-term follow-up in peripartum cardiomyopathy patients with contemporary treatment: low mortality, high cardiac recovery, but significant cardiovascular co-morbidities
    Moulig, Valeska
    Pfeffer, Tobias Jonathan
    Ricke-Hoch, Melanie
    Schlothauer, Stella
    Koenig, Tobias
    Schwab, Johannes
    Berliner, Dominik
    Pfister, Roman
    Michels, Guido
    Haghikia, Arash
    Falk, Christine S.
    Duncker, David
    Veltmann, Christian
    Hilfiker-Kleiner, Denise
    Bauersachs, Johann
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (12) : 1534 - 1542
  • [29] LONG-TERM FOLLOW-UP OF MEDICAL VERSUS SURGICAL THERAPY FOR HYPERTROPHIC CARDIOMYOPATHY - A RETROSPECTIVE STUDY
    SEILER, C
    HESS, OM
    SCHOENBECK, M
    TURINA, J
    JENNI, R
    TURINA, M
    KRAYENBUEHL, HP
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 17 (03) : 634 - 642
  • [30] EFFECTIVENESS OF LONG-TERM BETA-BLOCKER THERAPY FOR DILATED CARDIOMYOPATHY - ECHOCARDIOGRAPHICAL FOLLOW-UP
    FUKUNAMI, M
    HASHIMURA, K
    OHMORI, M
    IKEDA, T
    UMEMOTO, K
    KUMAGAI, K
    SAKAI, A
    YAMADA, T
    KONDOH, N
    MINAMINO, T
    NAGAREDA, T
    KOTOH, K
    HOKI, N
    CARDIOVASCULAR DRUGS AND THERAPY, 1991, 5 (02) : 463 - 469